Healthcare Industry News: pulse oximeter
News Release - August 18, 2015
Nihon Kohden Secures Neurodiagnostic Contract with NovationIRVINE, Calif.--(Healthcare Sales & Marketing Network)--Nihon Kohden, a U.S. market leader in patient monitoring, sleep assessment, neurology and cardiology instrumentation solutions, has entered into a three-year, dual-source agreement to provide sleep assessment/neurodiagnostic services and equipment for Novation, a leading health care services company. The contract, effective July 1, 2015, provides Nihon Kohden access to the more than 100,000 members and affiliates of VHA, UHC, Children’s Hospital Association and Provista that Novation serves.
“We are honored to be a partner with Novation, as our two organizations share a commitment to leading healthcare innovation that increases quality across the continuum,” said Wilson Constantine, chief executive officer, Nihon Kohden America. “The organization’s deep customer base will enable us to further our goal of providing integrated solutions that work across care areas. We look forward to working together to help improve and streamline healthcare delivery in this country.”
Nihon Kohden is a leader in the neurodiagnostic field with complete technology solutions known for their quality and reliability. The company’s first-to-market neurodiagnostic innovations include the world’s first electroencephalograph (EEG).
“We conducted a rigorous procurement process for this contract, and Nihon Kohden provided competitive clinical and financial value for the members and affiliates we serve,” said Mike Clemens, vice president of contracts and program services, Novation. “Nihon Kohden has committed to identifying cutting-edge solutions that have been effective in one area of healthcare and leveraging them to improve care in another area. This is an organization that shares our mission of improving healthcare quality.”
About Novation, Recipient of the Ethisphere Institute’s Ethics Inside Certification
Novation is the nation’s leading health care services company, focused on revolutionizing operational performance for more than 100,000 members and affiliates of VHA Inc., UHC, Children’s Hospital Association and Provista LLC. Novation’s progressive approach to cost performance, data and intelligence, and integrated advisory solutions helps health care providers envision and advance new models of cost-effective, high-quality care. Headquartered in Irving, Texas, Novation is committed to the highest standards of ethical behavior and twice has been honored with the Ethisphere Institute’s coveted Ethics Inside® Certification, and has been named four years consecutively to Ethisphere’s World’s Most Ethical Companies list. To learn more about Novation, please visit novationco.com and follow @NovationNews on Twitter.
About Nihon Kohden Corporation
Founded in Japan in 1951, Nihon Kohden is the leading manufacturer, developer and distributor of medical electronic equipment, with subsidiaries in the U.S., Europe and Asia. The company’s products are now used in more than 120 countries, and it is the largest supplier of electroencephalography products worldwide. A pioneer in transformational healthcare technology, Nihon Kohden has envisioned, designed and produced revolutionary devices, such as pulse oximeters, arrhythmia analysis, low-invasive blood volume monitoring and wireless patient monitoring. In the U.S., the company is a trusted source for patient monitoring, sleep assessment, neurology and cardiology instrumentation solutions, and has been recognized for the highest customer satisfaction among U.S. hospitals and health systems for 34 consecutive quarters (MD Buyline). For more information, visit www.nihonkohden.com and www.nkusa.com.
Source: Nihon Kohden
Issuer of this News Release is solely responsible for its
Please address inquiries directly to the issuing company.